Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piro Lito

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|February 4, 2016
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanismPiro Lito, Martha Solomon, Lian-Sheng Li, et al.
Science (New York, N.Y.)|October 7, 2021
The G protein signaling regulator RGS3 enhances the GTPase activity of KRASChuanchuan Li, Alberto Vides, Dongsung Kim, et al.
The Journal of Biological Chemistry|November 15, 2008
Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblastsPiro Lito, Bryan D Mets, Daniel M Appledorn, et al.
The Journal of Biological Chemistry|December 1, 2007
Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblastsPiro Lito, Bryan D Mets, Susanne Kleff, et al.
The American Journal of the Medical Sciences|January 22, 2009
Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic seriesPiro Lito, Liron Pantanowitz, Jonathan Marotti, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Preclinical Evaluation of [<sup>124</sup>I]-Sotorasib for the Imaging of Kirsten Rat Sarcoma G12C Mutant TumorsRaik Artschwager, Teja M Kalidindi, Delissa Johnson, et al.
Cancer Cell|March 15, 2022
With one eye on the futureCarlos Caldas, Maria Rescigno, Samra Turajlic, et al.
Nature|October 30, 2024
Pharmacological restoration of GTP hydrolysis by mutant RASAntonio Cuevas-Navarro, Yasin Pourfarjam, Feng Hu, et al.
Nature|January 10, 2020
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibitionJenny Y Xue, Yulei Zhao, Jordan Aronowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|February 4, 2016
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanismPiro Lito, Martha Solomon, Lian-Sheng Li, et al.
Science (New York, N.Y.)|October 7, 2021
The G protein signaling regulator RGS3 enhances the GTPase activity of KRASChuanchuan Li, Alberto Vides, Dongsung Kim, et al.
The Journal of Biological Chemistry|November 15, 2008
Sprouty 2 regulates DNA damage-induced apoptosis in Ras-transformed human fibroblastsPiro Lito, Bryan D Mets, Daniel M Appledorn, et al.
The Journal of Biological Chemistry|December 1, 2007
Evidence that sprouty 2 is necessary for sarcoma formation by H-Ras oncogene-transformed human fibroblastsPiro Lito, Bryan D Mets, Susanne Kleff, et al.
The American Journal of the Medical Sciences|January 22, 2009
Gastroenteropancreatic neuroendocrine tumors in patients with HIV infection: a trans-Atlantic seriesPiro Lito, Liron Pantanowitz, Jonathan Marotti, et al.
ACS Pharmacology & Translational Science|December 19, 2024
Preclinical Evaluation of [<sup>124</sup>I]-Sotorasib for the Imaging of Kirsten Rat Sarcoma G12C Mutant TumorsRaik Artschwager, Teja M Kalidindi, Delissa Johnson, et al.
Cancer Cell|March 15, 2022
With one eye on the futureCarlos Caldas, Maria Rescigno, Samra Turajlic, et al.
Nature|October 30, 2024
Pharmacological restoration of GTP hydrolysis by mutant RASAntonio Cuevas-Navarro, Yasin Pourfarjam, Feng Hu, et al.
Nature|January 10, 2020
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibitionJenny Y Xue, Yulei Zhao, Jordan Aronowitz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2019
Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway ActivationVictoria E Wang, Jenny Y Xue, Dennie T Frederick, et al.
Pageof 5